Swedish Consumer Durables Stock News

Why NIBE Industrier’s latest results matter for shareholders NIBE Industrier (OM:NIBE B) has drawn fresh attention after its Q4 2025 results showed operating margins at 13.1%, solid full year growth, higher net income, and a newly announced annual dividend. See our latest analysis for NIBE Industrier. The Q4 update and dividend news have arrived alongside a strong 90 day share price return of 21.15% and a 1 month share price return of 7.59%. However, the 1 year total shareholder return of...

Why Evolution’s latest earnings matter for shareholders Evolution (OM:EVO) has come under closer scrutiny after reporting its fourth quarter and full year 2025 results, with both revenue and net income lower than the prior year. This has prompted fresh questions about the stock’s recent slide. See our latest analysis for Evolution. The share price has retreated to SEK523.6, with a 1-day share price decline of 2.42% and a year-to-date share price decline of 16.12%, while the 1-year total...

Sales update and why it matters for Clas Ohlson (OM:CLAS B) Clas Ohlson (OM:CLAS B) just released its January 2026 sales update, reporting SEK 1,005 million for the month and SEK 9,903 million year to date, with 7% growth driven entirely by 9% organic expansion. See our latest analysis for Clas Ohlson. The January sales update comes as Clas Ohlson’s share price has gained 6.26% over the past week and 17.38% over the past month, with a 1 year total shareholder return of 42.36%, suggesting...

Vitrolife (OM:VITR) is back in focus after reporting fourth quarter and full year 2025 results, with sales of SEK 891 million for the quarter and a net loss of SEK 5,314 million. See our latest analysis for Vitrolife. Despite a 4.36% 1 day share price gain to SEK89.7 after the earnings release, Vitrolife’s 30 day share price return of 32.61% and 1 year total shareholder return of 56.22% indicate pressure has been building for some time as investors reassess the business after the large...

Medicover (OM:MCOV B) is back in focus after reporting fourth quarter and full year 2025 results, with higher sales and net income from continuing operations compared with the previous year. See our latest analysis for Medicover. The earnings release has drawn fresh attention to Medicover, with the share price at SEK209.0 and recent trading showing mixed momentum, including a 7 day share price return of 2.70% and a 90 day share price return of 11.25%. The 5 year total shareholder return of...

Balancing higher sales and wider losses Verisure (OM:VSURE) has drawn fresh attention after reporting Q4 and full year 2025 results, with sales of €964.7 million in the quarter and €3.7b for the year alongside wider net losses. That mix of higher revenue and larger losses gives you a lot to weigh up, especially given the stock’s recent negative returns over the month and past 3 months. Here is how those headline figures fit together. See our latest analysis for Verisure. Verisure’s latest...

Investors in Nederman Holding AB (publ) ( STO:NMAN ) had a good week, as its shares rose 2.9% to close at kr147...

Enity Holding AB (publ) ( STO:ENITY ) shareholders won't be pleased to see that the share price has had a very rough...

It's been a good week for RaySearch Laboratories AB (publ) ( STO:RAY B ) shareholders, because the company has just...

A week ago, Genovis AB (publ.) ( STO:GENO ) came out with a strong set of yearly numbers that could potentially lead to...

Last week saw the newest yearly earnings release from Swedencare AB (publ) ( STO:SECARE ), an important milestone in...

Devyser Diagnostics AB (publ) ( STO:DVYSR ) shareholders are probably feeling a little disappointed, since its shares...

The Gapwaves AB (publ) ( STO:GAPW B ) share price has fared very poorly over the last month, falling by a substantial...

Teqnion (OM:TEQ) has just posted a mixed set of FY 2025 figures, with Q3 revenue at SEK455.6 million and a basic EPS loss of SEK1.31, while trailing 12 month revenue stands at SEK1,742.1 million and EPS at SEK3.79 as one off gains and weaker profitability in the most recent year filter through the numbers. Over recent quarters the company has seen revenue move from SEK381.8 million in Q3 2024 to SEK405.7 million in Q4 2024, then up to SEK406.3 million in Q1 2025 and SEK474.5 million in Q2...

Karnell Group (OM:KARNEL B) has put up a busy FY 2025 so far, with Q3 revenue of SEK436 million and EPS of SEK0.88 setting the tone against a backdrop of trailing 12 month EPS of SEK2.52 and revenue of SEK1.63 billion, alongside reported earnings growth of 129.6% year on year. The company has seen quarterly revenue move from SEK356.6 million in Q3 2024 to SEK402.9 million in Q4 2024 and then SEK436 million in Q3 2025, while EPS has shifted from SEK0.55 to SEK0.57 and then SEK0.88 over the...

Saab (OM:SAAB B) just signed a Memorandum of Understanding with Ukrainian Defense Industry at the Munich Security Conference, targeting cooperation in aviation and airborne surveillance to support Ukraine’s defence capabilities. See our latest analysis for Saab. That Munich Security Conference MoU arrives after a busy start to the year, with Saab reporting higher full year 2025 sales and earnings and proposing a higher dividend. The 90 day share price return of 21.56% and a very large 5 year...

Last week, you might have seen that Mips AB (publ) ( STO:MIPS ) released its full-year result to the market. The early...

Last week, you might have seen that Storytel AB (publ) ( STO:STORY B ) released its full-year result to the market. The...

The market shrugged off AVTECH Sweden AB (publ)'s ( STO:AVT B ) solid earnings report. We think that investors might be...

Coor Service Management Holding AB's ( STO:COOR ) dividend will be increasing from last year's payment of the same...

Yubico (OM:YUBICO) FY 2025 earnings snapshot Yubico (OM:YUBICO) has wrapped up FY 2025 with Q4 revenue of 548.3 million SEK and basic EPS of 0.04 SEK, setting the tone for a year where trailing 12 month revenue came in at 2.2 billion SEK and basic EPS was 1.49 SEK. The company has seen quarterly revenue move between 499.1 million SEK and 623.1 million SEK over the past year, with basic EPS ranging from 0.04 SEK to 0.74 SEK. Trailing 12 month EPS and net income have tracked alongside 12 month...

Verisure (OM:VSURE) FY 2025 Earnings Snapshot Verisure (OM:VSURE) has wrapped up FY 2025 with fourth quarter revenue of €964.7 million and a basic EPS loss of €0.12, while trailing 12 month figures show revenue of about €3.7 billion and a basic EPS loss of €0.30. Over the past year, the company has seen revenue move from €870.2 million in Q4 2024 to €964.7 million in Q4 2025, while quarterly EPS stayed in loss making territory, shifting from a €0.07 loss per share in Q4 2024 to a €0.12 loss...

If you are looking at EQT and wondering whether the current share price still offers value, this article will walk you through what the numbers actually say about the stock. The share price last closed at SEK 290.30, with returns of 2.0% over 7 days, a 19.4% decline over 30 days, and returns of 20.7% over 3 years and 21.8% over 5 years that give useful longer term context. Recent coverage of EQT has focused on how the stock's shorter term pullback sits against its longer term record. This...

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...